Cordlife Suspended from New Cord Blood Collection by MOH

The Cordlife Group is no longer permitted to collect, test, process, or store new cord blood units following a suspension issued by the Ministry of Health (MOH) in Singapore. This regulatory action took effect on November 26, 2025, as the company failed to meet crucial health and safety requirements.

According to a press release from the MOH, Cordlife’s suspension prohibits the company from gathering any new cord blood units (CBUs). They may, however, continue to maintain and manage existing units under certain conditions. These actions include facilitating the transfer of stored CBUs to other banks and disposing of them in line with client instructions.

Regulatory Action Follows Previous Warning

This suspension follows a notice of intent issued by the MOH in September regarding the potential suspension of Cordlife’s license. After a review of Cordlife’s written response to the MOH, officials determined that the company had not sufficiently addressed concerns raised during a mid-point audit conducted in July 2025. The MOH concluded that Cordlife could not continue its cord blood banking services safely and ethically.

The MOH emphasized the need for Cordlife to rectify its operational shortcomings to ensure compliance with the Healthcare Services Act. Consequently, regulatory conditions will remain in place even if Cordlife’s license is renewed in January 2026. The company must demonstrate consistent adherence to regulatory standards before being allowed to resume full operations.

Future Oversight and Compliance Requirements

As part of the regulatory conditions, the MOH has mandated that Cordlife replace its current clinical governance officer. Additionally, the organization is required to review all laboratory records for approximately 160 CBUs collected since January 2025. The MOH will closely monitor Cordlife’s corrective actions and is prepared to implement further regulatory measures should additional non-compliance be discovered.

The MOH’s decision aims to ensure the continuity and safety of existing cord blood units stored by Cordlife’s clients while addressing the identified lapses in the company’s processes.